NGNE
Price
$10.46
Change
+$0.81 (+8.39%)
Updated
Apr 2 closing price
Capitalization
156.16M
NRXS
Price
$2.15
Change
+$0.04 (+1.90%)
Updated
Apr 2 closing price
Capitalization
15.23M
48 days until earnings call
Ad is loading...

NGNE vs NRXS

Header iconNGNE vs NRXS Comparison
Open Charts NGNE vs NRXSBanner chart's image
Neurogene
Price$10.46
Change+$0.81 (+8.39%)
Volume$391.07K
Capitalization156.16M
Neuraxis
Price$2.15
Change+$0.04 (+1.90%)
Volume$51.96K
Capitalization15.23M
NGNE vs NRXS Comparison Chart
Loading...
NGNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NGNE vs. NRXS commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NGNE is a Hold and NRXS is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (NGNE: $9.65 vs. NRXS: $2.11)
Brand notoriety: NGNE and NRXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NGNE: 224% vs. NRXS: 33%
Market capitalization -- NGNE: $156.16M vs. NRXS: $15.23M
NGNE [@Biotechnology] is valued at $156.16M. NRXS’s [@Biotechnology] market capitalization is $15.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NGNE’s FA Score shows that 0 FA rating(s) are green whileNRXS’s FA Score has 0 green FA rating(s).

  • NGNE’s FA Score: 0 green, 5 red.
  • NRXS’s FA Score: 0 green, 5 red.
According to our system of comparison, both NGNE and NRXS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NGNE’s TA Score shows that 4 TA indicator(s) are bullish while NRXS’s TA Score has 3 bullish TA indicator(s).

  • NGNE’s TA Score: 4 bullish, 4 bearish.
  • NRXS’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, NGNE is a better buy in the short-term than NRXS.

Price Growth

NGNE (@Biotechnology) experienced а -32.01% price change this week, while NRXS (@Biotechnology) price change was -3.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.27%. For the same industry, the average monthly price growth was -7.37%, and the average quarterly price growth was -12.08%.

Reported Earning Dates

NGNE is expected to report earnings on Nov 14, 2023.

NRXS is expected to report earnings on May 21, 2025.

Industries' Descriptions

@Biotechnology (-5.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NGNE($156M) has a higher market cap than NRXS($15.2M). NRXS YTD gains are higher at: -8.511 vs. NGNE (-54.243). NRXS has higher annual earnings (EBITDA): -8.02M vs. NGNE (-49.96M). NGNE has more cash in the bank: 139M vs. NRXS (261K). NRXS has less debt than NGNE: NRXS (477K) vs NGNE (14.5M). NRXS has higher revenues than NGNE: NRXS (2.46M) vs NGNE (925K).
NGNENRXSNGNE / NRXS
Capitalization156M15.2M1,026%
EBITDA-49.96M-8.02M623%
Gain YTD-54.243-8.511637%
P/E RatioN/AN/A-
Revenue925K2.46M38%
Total Cash139M261K53,257%
Total Debt14.5M477K3,040%
FUNDAMENTALS RATINGS
NGNE: Fundamental Ratings
NGNE
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NGNENRXS
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
85%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
NGNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BUFMX15.64N/A
N/A
Buffalo Mid Cap Growth
FHUMX14.15N/A
N/A
Federated Hermes US SMID Institutional
GEQYX56.20N/A
N/A
GuideStone Funds Equity Index Instl
RCGTX11.81N/A
N/A
Virtus Zevenbergen Technology C
MNHCX24.37N/A
N/A
Manning & Napier Pro-Blend Max Term L

NGNE and

Correlation & Price change

A.I.dvisor indicates that over the last year, NGNE has been loosely correlated with BRNS. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if NGNE jumps, then BRNS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NGNE
1D Price
Change %
NGNE100%
+8.34%
BRNS - NGNE
51%
Loosely correlated
-5.55%
RNAZ - NGNE
48%
Loosely correlated
-2.29%
SNDX - NGNE
43%
Loosely correlated
+7.99%
ZNTL - NGNE
41%
Loosely correlated
-2.52%
BPTSY - NGNE
38%
Loosely correlated
N/A
More

NRXS and

Correlation & Price change

A.I.dvisor tells us that NRXS and NGNE have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NRXS and NGNE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXS
1D Price
Change %
NRXS100%
+1.90%
NGNE - NRXS
24%
Poorly correlated
+8.34%
TCRT - NRXS
23%
Poorly correlated
+29.63%
ESLA - NRXS
22%
Poorly correlated
+6.71%
VTYX - NRXS
21%
Poorly correlated
-0.93%
TBPH - NRXS
21%
Poorly correlated
-0.11%
More